Edible and biocompatible metal-organic frameworks
원문보기
IPC분류정보
국가/구분
United States(US) Patent
등록
국제특허분류(IPC7판)
A61K-038/00
A01N-025/00
A61K-047/00
출원번호
US-0680141
(2008-09-25)
등록번호
US-8691748
(2014-04-08)
국제출원번호
PCT/US2008/077741
(2008-09-25)
§371/§102 date
20100623
(20100623)
국제공개번호
WO2009/042802
(2009-04-02)
발명자
/ 주소
Yaghi, Omar M.
El-Kadri, Oussama M.
Fang, Qianrong
Li, Qiaowei
출원인 / 주소
The Regents of the University of California
대리인 / 주소
Baker, Jr., Joseph R.
인용정보
피인용 횟수 :
0인용 특허 :
27
초록
The disclosure relates generally to materials that comprise organic frameworks. The disclosure also relates to materials that are useful to store and separate biological agents that are environmentally friendly and biocompatible.
대표청구항▼
1. A biocompatible metal-organic framework (bMOF) comprising: a plurality of biocompatible metallic cores;a plurality of biocompatible organic linking ligands that covalently connect adjacent biocompatible metallic cores of the plurality of biocompatible metallic cores, anda plurality of pores, wher
1. A biocompatible metal-organic framework (bMOF) comprising: a plurality of biocompatible metallic cores;a plurality of biocompatible organic linking ligands that covalently connect adjacent biocompatible metallic cores of the plurality of biocompatible metallic cores, anda plurality of pores, wherein the plurality of linked biocompatible metallic cores defines the pores,wherein the biocompatible metallic cores comprise a metal ion selected from the group consisting of Li+, Na+, Rb+, Mg2+, Ca2+, Sr2+, Ba2+, Sc3+, Ti4+, Zr4+, Ta3+, Mo3+, W3+, Mn3+, Co3+, Co2+, Ni2+, Ni+, Pd2+, Pd+, Pt2+, Pt+, Cu2+, Cu+, Au+, Zn2+, Al3+, Ga3+, In3+, Si4+, Si2+, Ge4+, Ge2+, Sn4+, Sn2+, Bi5+, Bi3+, and combinations thereof, andwherein the organic linking ligands comprise anions of parent compounds selected from the group consisting of citric acid, malic acid, tartaric acid, and folic acid. 2. The bMOF of claim 1, wherein the plurality of biocompatible metallic cores are heterogeneous. 3. The bMOF of claim 1, wherein the plurality of organic linking ligands are heterogeneous. 4. The bMOF of claim 1, wherein each ligand of the plurality of multidentate linking ligands includes two or more carboxylates. 5. The bMOF of claim 1 further comprising a guest species. 6. The bMOF of claim 5, wherein the guest species increase the surface area of the bMOF. 7. The bMOF of claim 5, wherein the guest species is biological agent. 8. The bMOF of claim 7, wherein the biological agent is a protein, lipid, nucleic acid or small molecule agent. 9. The bMOF of claim 7, wherein the biological agent is a therapeutic agent. 10. The bMOF of claim 7, wherein the biological agent is a diagnostic agent. 11. The bMOF of claim 1, further comprising interpenetrating bMOFs that increases the surface area. 12. The bMOF of claim 1, further comprising an adsorbed chemical species. 13. The bMOF of claim 12, wherein the adsorbed chemical species is selected from the group consisting of ammonia, carbon dioxide, carbon monoxide, hydrogen, amines, methane, oxygen, argon, nitrogen, argon, organic dyes, polycyclic organic molecules, and combinations thereof. 14. A dietary supplement comprising a bMOF of claim 1. 15. A drug delivery agent comprising the bMOF of claim 1. 16. A gas storage device comprising a bMOF of claim 1. 17. A method of making an environmentally friendly metal organic framework, comprising: reacting a plurality of metal clusters, each metal cluster comprising one or more metal ions selected from the group consisting of Li+, Na+, Rb+, Mg2+, Ca2+, Sr2+, Ba2+, Sc3+, Ti4+, Zr4+, Ta3+, Mo3+, W3+, Mn3+, Co3+, Co2+, Ni2+, Ni+, Pd2+, Pd+, Pd+, Pt+, Cu2+, Cu+, Au+, Zn2+, Al3+, Ga3+, In3+, Si4+, Si2+, Ge4+, Ge2+, Sn4+, Sn2+, Bi5+, Bi3+, and combinations thereof with one or more non toxic charged multidentate organic linking ligands that connect adjacent metal clusters,wherein the organic linking ligands comprise anions of parent compounds selected from the group consisting of citric acid, malic acid, tartaric acid, and folic acid. 18. A porous framework material comprising a plurality of biocompatible metallic cores, each core comprising one or more metal ions selected from the group consisting of Li+, Na+, Rb+, Mg2+, Ca2+, Sr2+, Ba2+, Sc3+, Ti4+, Zr4+, Ta3+, Mo3+, W3+, Mn3+, Co3+, Co2+, Ni2+, Ni+, Pd2+, Pd+, Pt2+, Pt+, Cu2+, Cu+, Au+, Zn2+, Al3+, Ga3+, In3+, Si4+, Si2+, Ge4+, Ge2+, Sn4+, Sn2+, Bi5+, Bi3+, and combinations thereof, wherein each core is linked to at least one other core through a plurality of biocompatible organic linking ligands, wherein the linking ligand comprises at least two carboxylates, and a plurality of pores,wherein the plurality of linked cores defines the pores, andwherein the framework material further comprises one or more drugs within the pores of the framework, wherein the drug is a peptide, polypeptide, protein, nucleic acid, fatty acid or small organic molecule. 19. The porous framework material of claim 18, wherein the organic linking ligand is selected from the group consisting of citrate, malate, and tartrate. 20. The porous framework material of claim 18, wherein the organic linking ligand is selected from the group consisting of malonate, succinate, glutarate, adipate, pimelate, suberate, maleate, fumarate, phthalate, isophthalate, terephthalate, hemimellitate, trimellitate, trimesate, malate, tartarate, and citrate. 21. The porous framework material of claim 18, wherein the organic linking ligand is selected from the group consisting of aldarate, malonate, malate, succinate, glutarate, adipate, tricarboxylates, isocitrate, aconitate, and propane-1,2,3-tricarboxylate (tricarballylate, and carballylate). 22. The porous framework material of claim 18, wherein the framework comprises repeating units having a general formula: wherein M is a non-toxic metal ion selected from the group consisting of Li+, Na+, Rb+, Mg2+, Ca2+, Sr2+, Ba2+, Sc3+, Ti4+, Zr4+, Ta3+, Mo3+, W3+, Mn3+, Co3+, Co2+, Ni2+, Ni+, Pd2+, Pd+, Pt2+, Pt+, Cu2+, Cu+, Au+, Zn2+, Al3+, Ga3+, In3+, Si4+, Si2+, Ge4+, Ge2+, Sn4+, Sn2+, Bi5+, Bi3+, and combinations thereof, and R is selected from the group consisting of —H, —OH, —OR1, aryl, substituted aryl, alkyl, substituted alkyl, carboxyl, aminocarbonyl, alkylsulfonylaminocarboxyl, alkoxycarbonyl, and halo, wherein R1 can be —H, and aryl, substituted aryl, alkyl, substituted alkyl, carboxyl, aminocarbonyl, alkylsulfonylaminocarboxyl, alkoxycarbonyl, and halo. 23. The porous framework material of claim 18, wherein the framework comprises repeating units having a general formula: wherein M is a non-toxic metal ion selected from the group consisting of Li+, Na+, Rb+, Mg2+, Ca2+, Sr2+, Ba2+, Sc3+, Ti4+, Zr4+, Ta3+, Mo3+, W3+, Mn3+, Co3+, Co2+, Ni2+, Ni+, Pd2+, Pd+, Pt2+, Pt+, Cu2+, Cu+, Au+, Zn2+, Al3+, Ga3+, In3+, Si4+, Si2+, Ge4+, Ge2+, Sn4+, Sn2+, Bi5+, Bi3+, and combinations thereof, and wherein n is 0, 1, or 2. 24. The porous framework material of claim 18, wherein the framework comprises repeating units having a general formula: wherein M is a non-toxic metal ion selected from the group consisting of Li+, Na+, Rb+, Mg2+, Ca2+, Sr2+, Ba2+, Sc3+, Ti4+, Zr4+, Ta3+, Mo3+, W3+, Mn3+, Co3+, Co2+, Ni2+, Ni+, Pd2+, Pd+, Pt2+, Pt+, Cu2+, Cu+, Au+, Zn2+, Al3+, Ga3+, In3+, Si4+, Si2+, Ge4+, Ge2+, Sn4+, Sn2+, Bi5+, Bi3+, and combinations thereof. 25. The porous framework material of claim 18, wherein the framework comprises repeating units having a general formula: wherein M is a non-toxic metal ion selected from the group consisting of Li+, Na+, Rb+, Mg2+, Ca2+, Sr2+, Ba2+, Sc3+, Ti4+, Zr4+, Ta3+, Mo3+, W3+, Mn3+, Co3+, Co2+, Ni2+, Ni+, Pd2+, Pd+, Pt2+, Pt+, Cu2+, Cu+, Au+, Zn2+, Al3+, Ga3+, In3+, Si4+, Si2+, Ge4+, Ge2+, Sn4+, Sn2+, Bi5+, Bi3+, and combinations thereof. 26. A porous framework material comprising a plurality of biocompatible metallic cores, each core linked to at least one other core; a plurality of biocompatible linking ligands that connects adjacent cores, wherein the linking ligand comprises at least two carboxylates, and a plurality of pores, wherein the plurality of linked cores defines the pores and a biological molecule chemically attached to a surface of pores of the porous framework, wherein the framework comprises repeating units having a general formula: wherein M is a non-toxic metal. 27. The porous framework material of claim 18, wherein the framework comprises repeating units having a general formula: wherein M is a non-toxic metal ion selected from the group consisting of Li+, Na+, Rb+, Mg2+, Ca2+, Sr2+, Ba2+, Sc3+, Ti4+, Zr4+, Ta3+, Mo3+, W3+, Mn3+, Co3+, Co2+, Ni2+, Ni+, Pd2+, Pd+, Pt2+, Pt+, Cu2+, Cu+, Au+, Zn2+, Al3+, Ga3+, In3+, Si4+, Si2+, Ge4+, Ge2+, Sn4+, Sn2+, Bi5+, Bi3+, and combinations thereof. 28. The porous framework material of claim 18, wherein the framework comprises repeating units having a general formula: wherein M is a non-toxic metal ion selected from the group consisting of Li+, Na+, Rb+, Mg2+, Ca2+, Sr2+, Ba2+, Sc3+, Ti4+, Zr4+, Ta3+, Mo3+, W3+, Mn3+, Co3+, Co2+, Ni2+, Ni+, Pd2+, Pd+, Pt2+, Pt+, Cu2+, Cu+, Au+, Zn2+, Al3+, Ga3+, In3+, Si4+, Si2+, Ge4+, Ge2+, Sn4+, Sn2+, Bi5+, Bi3+, and combinations thereof. 29. A porous framework material comprising a plurality of biocompatible metallic cores, each core linked to at least one other core; a plurality of biocompatible linking ligands that connects adjacent cores, wherein the linking ligand comprises at least two carboxylates, and a plurality of pores, wherein the plurality of linked cores defines a pore and a biological molecules chemically attached to a surface of pores of the porous framework, wherein the framework comprising repeating units having a general formula: wherein M is a non-toxic metal. 30. The porous framework material of claim 18, wherein the framework comprises a metaloxide of a metal ion selected from the group consisting of Li+, Na+, Rb+, Mg2+, Ca2+, Sr2+, Ba2+, Sc3+, Ti4+, Zr4+, Ta3+, Mo3+, W3+, Mn3+, Co3+, Co2+, Ni2+, Ni+, Pd2+, Pd+, Pt2+, Pt+, Cu2+, Cu+, Au+, Zn2+, Al3+, Ga3+, In3+, Si4+, Si2+, Ge4+, Ge2+, Sn4+, Sn2+, Bi5+, Bi3+, and combinations thereof. 31. The porous framework material of claim 18, wherein the biocompatible linking ligand comprises an alkyl or cycloalkyl group, consisting of 1 to 20 carbon atoms, an aryl group, consisting of 1 to 5 phenyl rings, or an alkyl or aryl amine, consisting of alkyl or cycloalkyl groups having from 1 to 20 carbon atoms or aryl groups consisting of 1 to 5 phenyl rings, and wherein a multidentate functional group is covalently bound to the ligand. 32. The porous framework material of claim 31, wherein the multidentate functional group can be selected from the group consisting of CO2H, CS2H, NO2, SO3H, Si(OH)3, Ge(OH)3, Sn(OH)3, Si(SH)4, Ge(SH)4, Sn(SH)4, PO3H, AsO3H, AsO4H, P(SH)3, As(SH)3, CH(RSH)2, C(RSH)3, CH(RNH2)2, C(RNH2)3, CH(ROH)2, C(ROH)3, CH(RCN)2, C(RCN)3, wherein R is an alkyl group having from 1 to 5 carbon atoms, or an aryl group consisting of 1 to 2 phenyl rings; and, CH(SH)2, C(SH)3, CH(NH2)2, C(NH2)3, CH(OH)2, C(OH)3, CH(CN)2, and C(CN)3. 33. A dietary supplement comprising a porous framework material of claim 20. 34. A method for delivery a drug to a subject comprising administering the porous framework of claim 20 to a subject.
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허에 인용된 특허 (27)
Dirk Johannes Bijl NL; Ronald Hage NL; Jan Kevelam NL; Jean Hypolites Koek NL; Dennis Stephen Murphy ; Irene Erica Smit NL; Johannes J. Verhagen NL; Pieter van der Vlist NL, Bleaching composition for dry cleaning containing transition metal bleach catalyst.
Yaghi, Omar M.; Matzger, Adam J.; Rowsell, Jesse L. C., Implementation of a strategy for achieving extraordinary levels of surface area and porosity in crystals.
Yaghi, Omar M.; Eddaoudi, Mohamed; Li, Hailian; Kim, Jaheon; Rosi, Nathaniel, Isoreticular metal-organic frameworks, process for forming the same, and systematic design of pore size and functionality therein, with application for gas storage.
Yaghi,Omar M.; Eddaoudi,Mohamed; Li,Hailian; Kim,Jaheon; Rosi,Nathaniel, Isoreticular metal-organic frameworks, process for forming the same, and systematic design of pore size and functionality therein, with application for gas storage.
Robert Timothy Stibrany ; Michael Gerard Matturro ; Stephen Zushma ; Abhimanyu Onkar Patil, Late transition metal catalyst complexes and oligomers therefrom.
Soo Hwaili (Charleston WV) Ream Bernard C. (Charleston WV) Robson John H. (Charleston WV), Mixed metal framework compositions for monoalkylene glycol production.
Mueller,Ulrich; Lippert,Gerald; Schubert,Olga; Hesse,Michael; Hess,Reinhard; Stoesser,Michael; Yaghi,Omar M., Process for preparing and organometallic framework material.
Mueller,Ulrich; Metelkina,Olga; Hesse,Michael; Stoesser,Michael; Haas,Peter; Yaghi,Omar, Process for the alkoxylation of monools in the presence of metallo-organic framework materials.
Mueller,Ulrich; Stoesser,Michael; Ruppel,Raimund; Baum,Eva; Bohres,Edward; Sigl,Marcus; Lobree,Lisa; Yaghi,Omar M.; Eddaoudi,Mohamed, Process for the alkoxylation of organic compounds in the presence of novel framework materials.
Muller, Ulrich; Lobree, Lisa; Hesse, Michael; Yaghi, Omar M.; Eddaoudi, Mohamed, Process for the epoxidation of an organic compound with oxygen or an oxygen-delivering compounds using catalysts containing metal-organic frame-work materials.
Ramprasad Dorai (Allentown PA) Pez Guido P. (Allentown PA) Pearlstein Ronald M. (Macungie PA) Meier Ingrid K. (Asbury NJ), Reversible oxygen sorbent compositions.
Chu Pochen (Voorhees NJ) Klocke Donald J. (Somerdale NJ) Marler David O. (Deptford NJ) McWilliams John P. (Woodbury NJ) Vartuli James C. (West Chester PA), Zeolite synthesis using an alcohol or like molecules.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.